You have a complaint against an EU institution or body?

Available languages:
  • ENEnglish

Refusal by EMA to disclose the identity of the pharmaceutical company which made a request for public access to the latest periodic safety update reports on Zyclara, a drug to treat actinic keratosis

Allegation(s)

EMA wrongly refused to grant access to the identity of the pharmaceutical company which on 23 September 2015 made a request for public access to the periodic safety update reports (PSURs) on Zyclara produced by the complainant.

Claim(s)

EMA should grant the complainant access to the identity of the pharmaceutical company.